IL1B and neoplasm: Bunt et al. [47] demonstrated that the inoculation of the IL-1β-promoted 4 T1 mammary carcinoma cells into mice increased the infiltration of MDSCs into tumor sites, whereas the accumulation of MDSCs into tumors was clearly delayed in the IL-1 receptor–deficient mice which also displayed reduced tumor growth.